Full-Time

Specimen Acquisition Business Integrator

Posted on 7/3/2025

Becton Dickinson

Becton Dickinson

10,001+ employees

Develops and sells medical devices and diagnostics

Compensation Overview

$169.7k - $305.7k/yr

Senior, Expert

Midland Park, NJ, USA

In Person

Category
Supply Chain Management
Operations & Logistics
Requirements
  • Strong communication skills
  • Leadership abilities
  • Experience in capacity management
  • Operations planning expertise
  • Collaboration with marketing, R&D, and supply chain
Responsibilities
  • Align ISC strategies with business/platform strategies
  • Develop ISC objectives and formulate operations plans
  • Ensure E2E execution of platform goals
  • Manage capacity needs and develop sourcing plans
  • Lead operations workstreams for new product development

BD (Becton, Dickinson and Company) focuses on improving health through medical technology. The company operates in three main areas: BD Medical, BD Life Sciences, and BD Interventional, each targeting different healthcare needs. BD develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products to hospitals, laboratories, and healthcare providers worldwide. Their products aim to enhance patient outcomes, reduce healthcare costs, and improve safety and efficiency in medical care. What sets BD apart from competitors is its comprehensive approach to healthcare solutions across various segments, allowing for a wide range of services and products. The company's goal is to advance healthcare by providing effective tools and technologies that support better medical discovery and care delivery.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eysins, Switzerland

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for telehealth boosts BD's remote patient monitoring devices.
  • Personalized medicine growth increases need for BD's advanced diagnostic tools.
  • Wearable medical devices market expansion offers BD new technology opportunities.

What critics are saying

  • Increased competition from emerging markets may impact BD's market share.
  • Rapid technological advancements require continuous R&D investment from BD.
  • Global talent shortage could affect BD's innovation and operational efficiency.

What makes Becton Dickinson unique

  • BD's $1.2B investment enhances syringe and drug delivery manufacturing capabilities.
  • Acquisition of Cubex LLC's assets boosts BD's cloud-based medical software offerings.
  • BD's global presence spans North America, EMEA, Greater Asia, and Latin America.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...

INACTIVE